摘要
目的探索艾滋病母婴传播阻断抗逆转录病毒治疗联合方案应用的影响因素,为制定促进人类免疫缺陷病毒(HIV)阳性孕妇及其所生婴儿抗病毒治疗联合用药的措施提供依据。方法在云南省5个艾滋病高、中度流行县(市、区),对艾滋病母婴传播阻断中选择抗病毒治疗联合方案的影响因素进行了定量和定性调查。结果抗逆转录病毒治疗联合方案应用率为53.2%(84/158)。主要影响因素是为了子女不被感染、不让抽血的风俗习惯、交通、经济、服药怕人知道、首次咨询孕周、医生的用药倾向、知道方案数目、身体健康状况、费用承受能力、知道有副作用、阻断成功的信心。结论抗逆转录病毒治疗联台方案的应用受多种因素影响。推广联合用药方案时要针对主要影响因素开展工作。
Objective To understand affecting factors in synthesized antineeroviral therapy（ART） in preventing mother -to- child HIV transmission, providing basis for making up measures of rational and canonical medicine using in ART. Methods Qualitative and quantitative methods for measuring use of regimen towards antiretrovirus therapy of PMTCT were used in a case - control study of mothers who received services of PMTCT from January, 2005 to March, 2007 in 5 HIV epidemic counties. Results Percentage of canonical medicine using in antivirus therapy was 53.2 % （84/158）. The main correlations with the using combined regimen of ART for positive pregnant women and their infants were as following： the sake of preventing children from infection, the customs of avoiding blood test, traffic, income, health status of HIV positive pregnant women, the knowledge of side effect, confidence of PMTCL, Conclusion Multiple factors affect the using combined regimen for antivirustherapy in PMTCT.
出处
《中国公共卫生》
CAS
CSCD
北大核心
2008年第6期725-726,共2页
Chinese Journal of Public Health
